Back to Search
STEPHEN LIPPMAN, M.D., PH.D.
M.D., PH.D.
Endocrinology, Diabetes & Metabolism Physician
NPI: 1962463216Individual
Specialties, Licenses & Credentials
Endocrinology, Diabetes & Metabolism PhysicianPrimary
Internal Medicine — Endocrinology, Diabetes & Metabolism
Code: 207RE0101X
D0035547(MD)
Research & Publications (20)
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
PMID 19066370·JAMA·2009
3-trial
Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
PMID 19318668·Chest·2009
8-other
Cancer prevention: from 1727 to milestones of the past 100 years.
PMID 19491253·Cancer Res·2009
6-review
Cancer prevention research: back to the future.
PMID 19491288·Cancer Prev Res (Phila)·2009
7-preclinical
Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".
PMID 19059972·Chest·2008
8-other
The convergent development of molecular-targeted drugs for cancer treatment and prevention.
PMID 17634526·Clin Cancer Res·2007
6-review
Reducing the "risk" of chemoprevention: defining and targeting high risk--2005 AACR Cancer Research and Prevention Foundation Award Lecture.
PMID 16540634·Cancer Res·2006
6-review
Fenretinide activity in retinoid-resistant oral leukoplakia.
PMID 16707609·Clin Cancer Res·2006
3-trial
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
PMID 15657339·J Natl Cancer Inst·2005
8-other
Oral cancer prevention and the evolution of molecular-targeted drug development.
PMID 15637397·J Clin Oncol·2005
6-review
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer.
PMID 11309437·J Natl Cancer Inst·2001
3-trial
Protease inhibitors in oral carcinogenesis and chemoprevention.
PMID 11156207·Clin Cancer Res·2000
6-review
American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.
PMID 19470930·J Clin Oncol·2009
6-review
Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
PMID 19528369·J Clin Oncol·2009
8-other
Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.
PMID 19571599·Oncology·2009
8-other
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants.
PMID 19584075·Cancer Prev Res (Phila)·2009
8-other
Microarray profiling of phage-display selections for rapid mapping of transcription factor-DNA interactions.
PMID 19360118·PLoS Genet·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 13538 EDGEMONT RD
SMITHSBURG, MD 21783 - Phone
- (301) 992-6301
Quick Facts
- NPI
- 1962463216
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile